GlaxoSmithKline (GSK) Tops Q1 EPS by 18c

GlaxoSmithKline (NYSE: GSK) reported Q1 EPS of $1.20, $0.18 better than the analyst estimate of $1.02. Revenue for the quarter came in at $10.06 billion versus the consensus estimate of $9.48 billion.

For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Boeing wins $121 million Navy contract for P-8A upgrades
• Qualcomm (QCOM) Is Said To Near Deal For Ai Chip Startup Modular - Bloomberg